Plans to open new R&D lab

Scroll Down

“We are extremely grateful to the City of Fishers and to the IEDC for making Fishers a supportive place to grow our business,” said Bill Vincent, CEO of Genezen. “Gene and cell therapies have shown amazing potential in treating cancer and rare genetic disorders, but manufacturing capacity has proven to be a bottleneck in advancing these therapies to help patients. Genezen’s expansion will not only help alleviate this challenge but will provide an anchor for developing other gene therapy and biotech companies in central Indiana.

See the full story on Inside Indiana Business.

You may also be interested in...

Genezen appoints Chief Commercial Officer to…

  Genezen, a cell and gene therapy Contract Development and Manufacturing...

Read more

Downstream Process Development for Lentiviral Vectors…

Lentiviral vectors (LVV) are commonly used as an efficient and safe...

Read more

Stable cell lines vs transient transfection…

The aim of upstream processing in viral vector development and manufacturing...

Read more

Genezen delivers next phase of cGMP…

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization...

Read more